Global Dengue Treatment Market Expectation Surges With Rising Demand And Changing Trends 2021-2028

Global Dengue Treatment Market

Data Bridge Market Research has added an exhaustive research study of the Global Dengue Treatment Market detailing every single market driver and intricately analyzing the business vertical. Global Dengue Treatment Market report brings together a meticulous study of the present and upcoming opportunities to elucidate the future investment in the industry. This report introduces top to bottom evaluation of the industry including empowering technologies, key trends, market drivers, challenges, standardization, regulatory landscape, opportunities, future guide, value chain, ecosystem player profiles and strategies. This report is a valuable source of assistance for companies and individuals that offers industry chain structure, business strategies and proposals for new project investments. The credible report also analyses various inhibitors as well as motivators of the market in both quantitative and qualitative manners to make available accurate information to the end users.

An excellent Global Dengue Treatment Market report describes complete market analysis with inputs from industry experts. While formulating this global market document, following aspects are kept into view and include market type, organization size, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. The world class market research analysis brings together a vast market place clearly into the focus. The research studies of report helps evaluate several important parameters that can be mentioned as investment in a rising market, success of a new product, and expansion of market share.

Global Dengue Treatment Market By Treatment (Medication, Supportive Care, Vaccination and Others), Drug Class (Analgesics, Antipyretics, Vaccines), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2027

Market Analysis: Global Dengue Treatment Market

Dengue treatment market is growing at a steady CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to the increasing prevalence of dengue in tropical and sub-tropical regions

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @

Competitive Analysis:

Dengue treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of dengue treatment for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the treatment market are F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Limited, ABIVAX, VabioTech, Sanofi, GlaxoSmithKline plc, Geneone Life Sciences, Novo Nordisk A/S, Karius, Inc, Implicit Bioscience, Hawaii Biotech Inc, Cerus Corporation, InBios International, Inc, Serum Institute of India Pvt. Ltd among others.

Market Outlook : Global Dengue Treatment Market

Dengue is also known as break bone fever, it is a mosquito borne viral infection which causes severe flu-like symptoms. It mainly occurs in tropical and subtropical areas of the world.  It can be mild or severe, mild dengue fever results in rashes, high fever, muscle and joint pain whereas severe dengue also called dengue hemorrhagic fever which causes high fever, severe bleeding, sudden drop in blood pressure (shock) and death. Symptoms of dengue fever usually begin after four to seven days of bitten by an infected mosquito which include very high fever up to 1040 F, headache, nausea, vomiting.

According to WHO, the actual number of cases for dengue are underreported and many cases are misclassified. In 2013, the estimation indicates that the occurrence of dengue fever is 390 million cases every year of which 96 million (67–136 million) manifest clinically.

For More Insights Get FREE Detailed TOC @

Key Developments in the Market

  • In July 2019, Serum Institute of India Pvt. Ltd is developing Dengushield, a monoclonal antibody for the treatment of dengue fever currently ongoing in phase l clinical trial. If trial gets successful, this biological drug will provide the potential treatment for patients with dengue.
  • In May 2019, Sanofi Pasteur Inc a subsidiary of Sanofi received approval from the FDA for Dengvaxia (Dengue Tetravalent Vaccine, Live) for the prevention of dengue disease caused by serotypes 1 – 4 of the virus in individuals 9 to 16 years of age in the United States. The approval of Dengvaxia provides critical medical prevention for patients living in the U.S. dengue endemic areas.

Market Drivers

  • Increased government funding to fight against dengue is accelerating the market growth
  • Unmet market needs of managing dengue burden around the world is boosting the market growth
  • Rise in medical insurance in developing countries is acting as catalyst to market growth for dengue treatment
  • Promising dengue pipeline is expected to drive the market growth in the forecast period

Market Restraints

  • Lack or insufficient healthcare infrastructure in underdeveloped and developing countries is hampering the market growth
  • Dearth awareness related to symptoms of dengue is hindering the market growth for dengue treatment
  • High cost of the treatment is also restraining the market growth

Buy this Report (Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries) @

Global Dengue Treatment Market Scope and Market Size:

Dengue Treatment Market is segmented of the basis of treatment, drug class, drug, route of administration, distribution channel and end user. The growth among these specific segments will help users analyze niche pockets of growth and strategies to approach the market and determine your core application areas and difference in your target markets.

Based on treatment, the dengue treatment market is segmented as medication, supportive care and vaccination.

Based on the drug class, the dengue treatment market is segmented into analgesics, antipyretics, vaccines and others.

Based on the route of administration, the dengue treatment market is segmented into oral and parenteral.

Based on the distribution channel, the dengue treatment market is segmented as hospital pharmacy, online pharmacy, retail pharmacy.

Based on end user, the dengue treatment market is segmented into hospitals, homecare, specialty clinics and others.

Global Dengue Treatment Market Country Level Analysis

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, Rest of Middle East and Africa as a part of Middle East and Africa, Argentina, Brazil, Peru and Rest of South America as part of South America.

Reasons to Purchase this Report:

  • Current and future of global dengue treatment market outlook in the developed and emerging markets.
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
  • The latest developments, market shares, and strategies that are employed by the major market players.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.



Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @


Back to top button